260 related articles for article (PubMed ID: 35139880)
21. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
[TBL] [Abstract][Full Text] [Related]
22. A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.
Woo XY; Srivastava A; Mack PC; Graber JH; Sanderson BJ; Lloyd MW; Chen M; Domanskyi S; Gandour-Edwards R; Tsai RA; Keck J; Cheng M; Bundy M; Jocoy EL; Riess JW; Holland W; Grubb SC; Peterson JG; Stafford GA; Paisie C; Neuhauser SB; Karuturi RKM; George J; Simons AK; Chavaree M; Tepper CG; Goodwin N; Airhart SD; Lara PN; Openshaw TH; Liu ET; Gandara DR; Bult CJ
Cancer Res; 2022 Nov; 82(22):4126-4138. PubMed ID: 36069866
[TBL] [Abstract][Full Text] [Related]
23. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.
Wu JQ; Zhai J; Li CY; Tan AM; Wei P; Shen LZ; He MF
J Exp Clin Cancer Res; 2017 Nov; 36(1):160. PubMed ID: 29141689
[TBL] [Abstract][Full Text] [Related]
24. Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib.
Raimbourg J; Joalland MP; Cabart M; de Plater L; Bouquet F; Savina A; Decaudin D; Bennouna J; Vallette FM; Lalier L
Mol Cancer Ther; 2017 Aug; 16(8):1634-1644. PubMed ID: 28522592
[TBL] [Abstract][Full Text] [Related]
25. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL
BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950
[TBL] [Abstract][Full Text] [Related]
26. Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non-small Cell Lung Cancer PDX Models with Driver Genetic Alterations.
Jo H; Yagishita S; Hayashi Y; Ryu S; Suzuki M; Kohsaka S; Ueno T; Matsumoto Y; Horinouchi H; Ohe Y; Watanabe SI; Motoi N; Yatabe Y; Mano H; Takahashi K; Hamada A
Mol Cancer Ther; 2022 Feb; 21(2):359-370. PubMed ID: 34911818
[TBL] [Abstract][Full Text] [Related]
27. Initiation and characterization of small cell lung cancer patient-derived xenografts from ultrasound-guided transbronchial needle aspirates.
Anderson WC; Boyd MB; Aguilar J; Pickell B; Laysang A; Pysz MA; Bheddah S; Ramoth J; Slingerland BC; Dylla SJ; Rubio ER
PLoS One; 2015; 10(5):e0125255. PubMed ID: 25955027
[TBL] [Abstract][Full Text] [Related]
28. Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis.
Wulf-Goldenberg A; Hoffmann J; Becker M; Brzezicha B; Walther W
Methods Mol Biol; 2021; 2294():43-58. PubMed ID: 33742393
[TBL] [Abstract][Full Text] [Related]
29. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
30. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
[TBL] [Abstract][Full Text] [Related]
32. Generation of stable PDX derived cell lines using conditional reprogramming.
Borodovsky A; McQuiston TJ; Stetson D; Ahmed A; Whitston D; Zhang J; Grondine M; Lawson D; Challberg SS; Zinda M; Pollok BA; Dougherty BA; D'Cruz CM
Mol Cancer; 2017 Dec; 16(1):177. PubMed ID: 29212548
[TBL] [Abstract][Full Text] [Related]
33. The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors.
Charbonneau M; Harper K; Brochu-Gaudreau K; Perreault A; Roy LO; Lucien F; Tian S; Fortin D; Dubois CM
Neuro Oncol; 2023 Sep; 25(9):1605-1616. PubMed ID: 36821432
[TBL] [Abstract][Full Text] [Related]
34. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S
Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771
[TBL] [Abstract][Full Text] [Related]
35. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
Yamaura T; Doki Y; Murakami K; Saiki I
Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
[TBL] [Abstract][Full Text] [Related]
36. Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
Zhang XC; Zhang J; Li M; Huang XS; Yang XN; Zhong WZ; Xie L; Zhang L; Zhou M; Gavine P; Su X; Zheng L; Zhu G; Zhan P; Ji Q; Wu YL
J Transl Med; 2013 Jul; 11():168. PubMed ID: 23842453
[TBL] [Abstract][Full Text] [Related]
37. Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.
Naumov GN; Nilsson MB; Cascone T; Briggs A; Straume O; Akslen LA; Lifshits E; Byers LA; Xu L; Wu HK; Jänne P; Kobayashi S; Halmos B; Tenen D; Tang XM; Engelman J; Yeap B; Folkman J; Johnson BE; Heymach JV
Clin Cancer Res; 2009 May; 15(10):3484-94. PubMed ID: 19447865
[TBL] [Abstract][Full Text] [Related]
38. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
[TBL] [Abstract][Full Text] [Related]
39. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
40. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
Zheng Q; Dong H; Mo J; Zhang Y; Huang J; Ouyang S; Shi S; Zhu K; Qu X; Hu W; Liu P; Wang Y; Zhang X
Theranostics; 2021; 11(2):824-840. PubMed ID: 33391507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
